NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 230 filers reported holding NEKTAR THERAPEUTICS in Q3 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $967 | -68.9% | 1,376 | 0.0% | 0.00% | – |
Q4 2022 | $3,110 | -22.2% | 1,376 | 0.0% | 0.00% | – |
Q3 2022 | $4,000 | -20.0% | 1,376 | 0.0% | 0.00% | – |
Q2 2022 | $5,000 | -28.6% | 1,376 | 0.0% | 0.00% | – |
Q1 2022 | $7,000 | -63.2% | 1,376 | 0.0% | 0.00% | – |
Q4 2021 | $19,000 | -24.0% | 1,376 | 0.0% | 0.00% | – |
Q3 2021 | $25,000 | -3.8% | 1,376 | -10.8% | 0.00% | – |
Q2 2021 | $26,000 | -16.1% | 1,542 | 0.0% | 0.00% | – |
Q1 2021 | $31,000 | +19.2% | 1,542 | +2.1% | 0.00% | – |
Q4 2020 | $26,000 | – | 1,511 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Monaco Asset Management SAM | 4,809,601 | $2,864,598 | 0.85% |
Lynx1 Capital Management LP | 1,766,815 | $1,052,315 | 0.70% |
CM Management, LLC | 800,000 | $476,480 | 0.51% |
Deep Track Capital, LP | 18,400,000 | $10,959,040 | 0.42% |
TANG CAPITAL MANAGEMENT LLC | 3,939,600 | $2,346,426 | 0.33% |
Acuitas Investments, LLC | 721,460 | $429,702 | 0.25% |
RA Capital Management | 18,700,000 | $11,137,720 | 0.22% |
GSA CAPITAL PARTNERS LLP | 1,841,078 | $1,097 | 0.09% |
UBS OCONNOR LLC | 1,376,249 | $820,244 | 0.02% |
Marquette Asset Management, LLC | 148,378 | $88,374 | 0.02% |